130 related articles for article (PubMed ID: 7562557)
1. Quantification of the in vivo potency of the adenosine A2 receptor antagonist 8-(3-chlorostyryl)caffeine.
Mathôt RA; Gubbens-Stibbe JM; Soudijn W; Jacobson KA; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 1995 Oct; 275(1):245-53. PubMed ID: 7562557
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic modelling of the haemodynamic effects of the A2a adenosine receptor agonist CGS 21680C in conscious normotensive rats.
Mathôt RA; Cleton A; Soudijn W; IJzerman AP; Danhof M
Br J Pharmacol; 1995 Feb; 114(4):761-8. PubMed ID: 7773536
[TBL] [Abstract][Full Text] [Related]
3. Partial agonism of the nonselective adenosine receptor agonist 8-butylaminoadenosine at the A1 receptor in vivo.
Mathot RA; Wenden EM; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
J Pharmacol Exp Ther; 1996 Dec; 279(3):1439-46. PubMed ID: 8968369
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic-haemodynamic relationships of 2-chloroadenosine at adenosine A1 and A2a receptors in vivo.
Mathoôt RA; Soudijn W; Breimer DD; Ijzerman AP; Danhof M
Br J Pharmacol; 1996 May; 118(2):369-77. PubMed ID: 8735640
[TBL] [Abstract][Full Text] [Related]
5. Effects of adenosine A2A receptor agonist, CGS 21680, on blood pressure, cardiac index and arterial conductance in anaesthetized rats.
Nekooeian AA; Tabrizchi R
Eur J Pharmacol; 1996 Jun; 307(2):163-9. PubMed ID: 8832218
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effects of adenosine A2 agonists in the conscious spontaneously hypertensive rat: a comparative study of three structurally distinct ligands.
Webb RL; Barclay BW; Graybill SC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1203-12. PubMed ID: 1684818
[TBL] [Abstract][Full Text] [Related]
7. Development of tolerance to the antihypertensive effects of highly selective adenosine A2a agonists upon chronic administration.
Webb RL; Sills MA; Chovan JP; Peppard JV; Francis JE
J Pharmacol Exp Ther; 1993 Oct; 267(1):287-95. PubMed ID: 8229754
[TBL] [Abstract][Full Text] [Related]
8. Modelling of the pharmacodynamic interaction of an A1 adenosine receptor agonist and antagonist in vivo: N6-cyclopentyladenosine and 8-cyclopentyltheophylline.
Appel S; Mathôt RA; Langemeijer MW; IJzerman AP; Danhof M
Br J Pharmacol; 1995 Aug; 115(7):1253-9. PubMed ID: 7582553
[TBL] [Abstract][Full Text] [Related]
9. Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Cunha RA; Johansson B; Constantino MD; Sebastião AM; Fredholm BB
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):261-71. PubMed ID: 8692280
[TBL] [Abstract][Full Text] [Related]
10. CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity.
Hutchison AJ; Webb RL; Oei HH; Ghai GR; Zimmerman MB; Williams M
J Pharmacol Exp Ther; 1989 Oct; 251(1):47-55. PubMed ID: 2795469
[TBL] [Abstract][Full Text] [Related]
11. Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.
Schindler CW; Karcz-Kubicha M; Thorndike EB; Müller CE; Tella SR; Ferré S; Goldberg SR
Br J Pharmacol; 2005 Mar; 144(5):642-50. PubMed ID: 15678095
[TBL] [Abstract][Full Text] [Related]
12. Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats.
Baldo BA; Koob GF; Markou A
J Neurosci; 1999 Dec; 19(24):11017-26. PubMed ID: 10594082
[TBL] [Abstract][Full Text] [Related]
13. Ligand-activation of the adenosine A2a receptors inhibits IL-12 production by human monocytes.
Link AA; Kino T; Worth JA; McGuire JL; Crane ML; Chrousos GP; Wilder RL; Elenkov IJ
J Immunol; 2000 Jan; 164(1):436-42. PubMed ID: 10605040
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of strychnine-allodynia is mediated by spinal adenosine A1- but not A2-receptors in the rat.
Khandwala H; Zhang Z; Loomis CW
Brain Res; 1998 Oct; 808(1):106-9. PubMed ID: 9795169
[TBL] [Abstract][Full Text] [Related]
15. Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.
Hiley CR; Bottrill FE; Warnock J; Richardson PJ
Br J Pharmacol; 1995 Nov; 116(6):2641-6. PubMed ID: 8590983
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic modelling of the anti-lipolytic and anti-ketotic effects of the adenosine A1-receptor agonist N6-(p-sulphophenyl)adenosine in rats.
van Schaick EA; de Greef HJ; Langemeijer MW; Sheehan MJ; IJzerman AP; Danhof M
Br J Pharmacol; 1997 Oct; 122(3):525-33. PubMed ID: 9351510
[TBL] [Abstract][Full Text] [Related]
17. Characterization of biochemical effects of CGS 21680C, an A2-adenosine receptor agonist, in the mammalian ventricle.
Bokník P; Neumann J; Schmitz W; Scholz H; Wenzlaff H
J Cardiovasc Pharmacol; 1997 Dec; 30(6):750-8. PubMed ID: 9436814
[TBL] [Abstract][Full Text] [Related]
18. Effect of adenosine and some of its structural analogues on the conductance of NMDA receptor channels in a subset of rat neostriatal neurones.
Nörenberg W; Wirkner K; Illes P
Br J Pharmacol; 1997 Sep; 122(1):71-80. PubMed ID: 9298530
[TBL] [Abstract][Full Text] [Related]
19. Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
Von Lubitz DK; Lin RC; Jacobson KA
Eur J Pharmacol; 1995 Dec; 287(3):295-302. PubMed ID: 8991804
[TBL] [Abstract][Full Text] [Related]
20. Further characterization of [3H]-CGS 21680 binding sites in the rat striatum and cortex.
Kirk IP; Richardson PJ
Br J Pharmacol; 1995 Jan; 114(2):537-43. PubMed ID: 7881753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
